Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

11.81
BATS BZX Real-Time Price
As of 3:16pm ET
 +0.485 / +4.28%
Today’s Change
7.09
Today|||52-Week Range
12.11
+42.23%
Year-to-Date
No recent news for Supernus Pharmaceuticals Inc.

Today’s Trading

Previous close11.32
Today’s open11.37
Day’s range11.32 - 11.85
Volume678,513
Average volume (3 months)494,640
Market cap$499.1M
Dividend yield--
Data as of 3:01pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+150.00%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+915.43%
P/E ratio30.0
Price/Sales2.87
Price/Book--

Competitors

 Today’s
change
Today’s
% change
LBIOLion Biotechnologies...-0.51-4.40%
RVNCRevance Therapeutics...-0.24-1.25%
SRPTSarepta Therapeutics...+0.47+3.60%
PRQRProQR Therapeutics N...-0.17-0.73%
Data as of 3:16pm ET, 03/27/2015

Financials

Next reporting dateMay 11, 2015
EPS forecast (this quarter)-$0.01
Annual revenue (last year)$122.0M
Annual profit (last year)$19.9M
Net profit margin16.28%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Director &
Secretary
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account